Ontozry 50 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ontozry 50 mg compresse rivestite con film

angelini pharma s.p.a., rom, zweigniederlassung zug - cenobamatum - compresse rivestite con film - cenobamatum 50 mg, cellulosum microcristallinum, lactosum monohydricum 158.68 mg, carboxymethylamylum natricum a corresp. natrium 0.64 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto. - antieptileptikum - synthetika

Ontozry 100 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ontozry 100 mg compresse rivestite con film

angelini pharma s.p.a., rom, zweigniederlassung zug - cenobamatum - compresse rivestite con film - cenobamatum 100 mg, cellulosum microcristallinum, lactosum monohydricum 108.68 mg, carboxymethylamylum natricum a corresp. natrium 0.64 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (flavum), e 172 (rubrum), e 132, pro compresso obducto. - antieptileptikum - synthetika

Ontozry 150 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ontozry 150 mg compresse rivestite con film

angelini pharma s.p.a., rom, zweigniederlassung zug - cenobamatum - compresse rivestite con film - cenobamatum 150 mg, cellulosum microcristallinum, lactosum monohydricum 163.02 mg, carboxymethylamylum natricum a corresp. natrium 0.96 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - antieptileptikum - synthetika

Ontozry 200 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ontozry 200 mg compresse rivestite con film

angelini pharma s.p.a., rom, zweigniederlassung zug - cenobamatum - compresse rivestite con film - cenobamatum 200 mg, cellulosum microcristallinum, lactosum monohydricum 217.36 mg, carboxymethylamylum natricum a corresp. natrium 1.28 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - antieptileptikum - synthetika

Ontozry 12.5 mg Tabletten und Ontozry 25 mg, Filmtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ontozry 12.5 mg tabletten und ontozry 25 mg, filmtabletten

angelini pharma s.p.a., rom, zweigniederlassung zug - cenobamatum - tabletten und ontozry 25 mg, filmtabletten - i) ontozry 12.5 mg, tablette: cenobamatum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 39.67 mg, carboxymethylamylum natricum a corresp. natrium 0.16 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. ii) ontozry 25 mg, filmtablette: cenobamatum 25 mg, cellulosum microcristallinum, lactosum monohydricum 79.34 mg, carboxymethylamylum natricum a corresp. natrium 0.32 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum, talcum, e 172 (flavum), e 172 (rubrum), e 132, pro compresso obducto. - antieptileptikum - synthetika

Teriflunomide Mylan Unione Europea - italiano - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Unione Europea - italiano - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori selettivi immunosoppressori - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

CLEFIREM Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

clefirem

bausch health ireland limited - teriflunomide - teriflunomide